Cover Image

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Samantha Shekar, Megan Crumbaker, Anthony Joshua, Andrew Yam, Phillip Stricker, Carlo Yuen, David Ende, Benjamin Namdarian, James Thompson, Raji Kooner, Gordon O'Neill, Jeremy Mo, Hao‐Wen Sim, George Hruby, Farshad Kasraei, Annie Ho, Jeremy De Leon
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
by: Ruth Pidsley, et al.
Published: (2024)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
by: Mohammadmehdi Adhami, et al.
Published: (2026)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2024)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
by: Stephen Langley, et al.
Published: (2024)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
by: Jennifer Ward, et al.
Published: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
by: Maxwell Louis Sandberg, et al.
Published: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
by: Eric Margolis, et al.
Published: (2025)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)

The carbon footprint of transperineal prostate biopsy
by: Daniel A. Carson, et al.
Published: (2025)

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
by: Alberto Costa Silva, et al.
Published: (2026)

Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
by: Sophia M. Abusamra, et al.
Published: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
by: Abel Tesfai, et al.
Published: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
by: Ansh Bhatia, et al.
Published: (2024)

Contemporary status of diagnostic endoluminal ultrasound and optical coherence tomography in the ureter
by: Samuel Sii, et al.
Published: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
by: Mohammed Shahait, et al.
Published: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
by: Ryan Sutherland, et al.
Published: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
by: Ailene E. Corona, et al.
Published: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
by: André B. Silva, et al.
Published: (2026)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
by: Joshua Yi Min Tung, et al.
Published: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
by: Mathew Thakur, et al.
Published: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
by: Nikhil Mayor, et al.
Published: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
by: Nadia Rokan, et al.
Published: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
by: Emilien Seizilles de Mazancourt, et al.
Published: (2025)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
by: Geneva Pantoja, et al.
Published: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
by: Lu Yu Kuo, et al.
Published: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
by: Pierre Allainguillaume, et al.
Published: (2026)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
by: Marcus Sondermann, et al.
Published: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
by: Muhammad Haider, et al.
Published: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
by: Sandra Irenaeus, et al.
Published: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
by: Alan Priester, et al.
Published: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
by: Austin Drysch, et al.
Published: (2025)